By Yi Liu, PharmD, PhD, PCCA Research Pharmacist

If you visited the PCCA Science booth during International Seminar 2019, you probably felt the breadth and depth of research going on at PCCA — case studies, dissecting rules and regulations, comprehensive formula analysis, new product testing, and much more. One example is an interesting case study about treating burn wounds in an immunocompromised adult conducted by Harbin Pharmacy in Birmingham, Alabama, one of PCCA’s member pharmacies. Beyond PCCA, independent researchers recently used Lipoderm^® in a study on improving wrinkles and skin texture in combination with laser treatment. We have recently added links to these resources to the PCCA Science webpage. 

Among the other items listed on the PCCA Science page, you don’t want to miss one important category: technical reports. This is especially true after the launch of a new base. Do you want to know how well our newest innovation, VersaBase^® Anhydrous HRT, delivers female hormones before your patients put it on their skin? Do you want to know if it is safe to switch your patients from another topical base to VersaBase Anhydrous HRT? You will be able to find the answers in our technical reports. These resources provide you quick access to the most recent data generated by PCCA’s Research and Development team. The studies are always conducted to present scientific evidence on the most important properties of PCCA products. The data is publication grade, scientifically designed and reproducible, ready for you to show to your prescribers and patients. Here are some newly released technical reports:

• Evaluation of Safety and Skin Irritancy of VersaBase Anhydrous HRT in Human Epidermis Model
• Evaluation of in Vitro Human Skin Percutaneous Absorption of Progesterone in VersaBase Anhydrous HRT
• Evaluation of in Vitro Human Skin Percutaneous Absorption of Testosterone in VersaBase Anhydrous HRT
• Evaluation of Safety and Skin Irritancy of PermE8™ Anhydrous Gel in Human Epidermis Model
• Evaluation of Safety and Skin Irritancy of W06™ Anhydrous Topical Gel in Human Epidermis Model

What are the other properties of PCCA bases you think are important to know? What data about the bases are you and your physicians eager to see? Go to our webpage and look for it under the Technical Reports tab. If your answer is not there, an easy thing to do is to email PCCAScience@pccarx.com, then let us to help you address those data concerns. We’re happy to hear about the needs of your pharmacy, practitioners and patients. The whole Research and Development team is driven by this and works diligently to development new products and techniques to provide you solutions. Talk with us to make sure your needs are being heard. Maybe next year at International Seminar, the unveiled new product will be exactly what you’ve been waiting for. 

Finally, here’s a sneak peek of the next PCCA Science update: Several manuscripts authored by PCCA have recently been accepted for publication in peer-reviewed journals, covering everything from clinical to regulatory topics. We will present these in the next PCCA Science post here on the blog. Stay tuned, and see you soon!

Yi Liu, PharmD, PhD, is a research pharmacist in the Research and Development department at PCCA. She joined PCCA as a clinical pharmacy researcher in the Clinical Services department in 2018 and started her current role in 2019. Yi graduated from Ohio University with a PhD in molecular and cellular biology in 2012. She also worked as a postdoctoral research fellow in the Houston Methodist Research Institute for three years prior to starting pharmacy school. Yi received her PharmD from the University of Houston College of Pharmacy in 2019.